Portfolio company
Enzyre
Netherlands · £850k raised
Raised
£850k
Latest stage
Series A
Rounds recorded
1
Backed by
4 investors
Sectors
About
This company develops a portable diagnostic device for haemophilia patients to monitor blood coagulation status and manage treatment from home.
SourceFunding history · 1
Similar companies
Entia
This company develops at-home blood monitoring devices for cancer patients to share results with healthcare providers and improve treatment management.
Aptatek Biosciences
This company develops portable diagnostic devices for home monitoring of biomarkers to help patients manage chronic conditions such as phenylketonuria.
Sanguina
This company develops digital health tools and home test kits that allow individuals to monitor their blood health and manage anaemia.
ProFactor Pharma
This company develops recombinant Factor VIII to treat haemophilia A in patients who currently lack access to affordable medication.
Diamontech
This company develops non-invasive laser technology for measuring blood glucose levels without finger pricking for people with diabetes.
LEUKO
This company develops a non-invasive device for monitoring white blood cell levels at home for cancer patients undergoing chemotherapy.
Plasmacure
This company develops cold plasma medical devices for healthcare professionals to treat chronic wounds such as diabetic foot ulcers and pressure sores.
Ferritiva
This company develops non-invasive diagnostic strips and sensors for monitoring iron deficiency using saliva or urine samples for athletes and at-risk populations.
